Endothelial cells are known to secrete various antiproliferative and vasodilating factors. Although injury of endothelial cells has been postulated as an initial trigger of the progression of atherosclerosis in patients with diabetes, the mechanisms of endothelial injury in diabetes are not yet clarified. Therefore, it is important to know the effects of high glucose on the factors that may influence endothelial cell growth. A novel member of endothelium-specific growth factors, hepatocyte growth factor (HGF), is produced in vascular cells. To investigate the effects of high glucose on vascular cells, we examined 1) the effects of high glucose on endothelial cell and vascular smooth muscle cell (VSMC) growth and 2) the effects of high glucose on local HGF production in endothelial cell and VSMC. Treatment of human aortic endothelial cell with a high concentration of D-glucose, but not mannitol and L-glucose, resulted in a significant decrease in cell number. Interestingly, addition of recombinant HGF attenuated high D-glucose–induced endothelial cell death. Therefore, we measured local HGF secretion of endothelial cell. Importantly, local HGF production was significantly decreased by high D-glucose treatment. In contrast, high D-glucose treatment resulted in a significant increase in the number of human aortic VSMCs, whereas local HGF production was significantly decreased in accordance with increase in D-glucose concentration. No significant changes in numbers were observed in VSMC treated with high mannitol and L-glucose. We also studied the mechanisms of local HGF suppression by high D-glucose. High D-glucose treatment stimulated transforming growth factor-β (TGF-β) concentration in endothelial cell and VSMC. Decreased local vascular HGF production was abolished by addition of anti-TGF-β antibody. As TGF-β inhibited local HGF production in endothelial cell and VSMC, increased TGF-β induced by high D-glucose may suppress local HGF production. This study demonstrated that high D-glucose induced endothelial cell death, stimulated VSMC growth, and decreased local HGF production through the stimulation of TGF-β production both in endothelial cell and VSMC. Overall, decrease in a local endothelial stimulant, HGF, by high D-glucose may be a trigger of endothelial injury in diabetes, potentially resulting in the progression of atherosclerosis.
Skip Nav Destination
Article navigation
Original Articles|
January 01 1997
Potential Role of an Endothelium-Specific Growth Factor, Hepatocyte Growth Factor, on Endothelial Damage in Diabetes Free
Ryuichi Morishita;
Ryuichi Morishita
2
Department of Oncology, Biomedical Research Center, Osaka University Medical School
Suita, Japan
Search for other works by this author on:
Shigefumi Nakamura;
Shigefumi Nakamura
2
Department of Oncology, Biomedical Research Center, Osaka University Medical School
Suita, Japan
Search for other works by this author on:
Yoshio Nakamura;
Yoshio Nakamura
2
Department of Oncology, Biomedical Research Center, Osaka University Medical School
Suita, Japan
Search for other works by this author on:
Motokuni Aoki;
Motokuni Aoki
2
Department of Oncology, Biomedical Research Center, Osaka University Medical School
Suita, Japan
Search for other works by this author on:
Atsushi Moriguchi;
Atsushi Moriguchi
2
Department of Oncology, Biomedical Research Center, Osaka University Medical School
Suita, Japan
Search for other works by this author on:
Iwao Kida;
Iwao Kida
2
Department of Oncology, Biomedical Research Center, Osaka University Medical School
Suita, Japan
Search for other works by this author on:
Yoshikage Yo;
Yoshikage Yo
2
Department of Oncology, Biomedical Research Center, Osaka University Medical School
Suita, Japan
Search for other works by this author on:
Kunio Matsumoto;
Kunio Matsumoto
1
Department of Geriatric Medicine and the Division of Biochemistry, Osaka University Medical School
Suita, Japan
Search for other works by this author on:
Toshikazu Nakamura;
Toshikazu Nakamura
1
Department of Geriatric Medicine and the Division of Biochemistry, Osaka University Medical School
Suita, Japan
Search for other works by this author on:
Jitsuo Higaki;
Jitsuo Higaki
2
Department of Oncology, Biomedical Research Center, Osaka University Medical School
Suita, Japan
Search for other works by this author on:
Toshio Ogihara
Toshio Ogihara
2
Department of Oncology, Biomedical Research Center, Osaka University Medical School
Suita, Japan
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Toshio Ogihara, Department of Geriatric Medicine, Osaka University Medical School, 2-2 Yamada-oka, Suita 565, Japan.
1
bFGF, basic fibroblast growth factor; DSF, defined serum free medium; ELISA, enzyme-linked immunosorbent assay; HGF, hepatocyte growth factor; PBS, phosphate-buffered saline; TGF-β, transforming growth factor-β; VSMC, vascular smooth muscle cell.
Diabetes 1997;46(1):138–142
Article history
Received:
April 12 1996
Revision Received:
August 01 1996
Accepted:
August 01 1996
PubMed:
8971094
Citation
Ryuichi Morishita, Shigefumi Nakamura, Yoshio Nakamura, Motokuni Aoki, Atsushi Moriguchi, Iwao Kida, Yoshikage Yo, Kunio Matsumoto, Toshikazu Nakamura, Jitsuo Higaki, Toshio Ogihara; Potential Role of an Endothelium-Specific Growth Factor, Hepatocyte Growth Factor, on Endothelial Damage in Diabetes. Diabetes 1 January 1997; 46 (1): 138–142. https://doi.org/10.2337/diab.46.1.138
Download citation file:
114
Views